Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Parsons

Showing results (391-400 of 424) with videos related to

Pageof 43
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Potent immunosuppressive C32-O-arylethyl ether derivatives of ascomycin with reduced toxicityH M Armstrong, F Wong, M A Holmes, et al.
The Journal of Biological Chemistry|March 11, 2020
AIG1 and ADTRP are endogenous hydrolases of fatty acid esters of hydroxy fatty acids (FAHFAs) in miceMeric Erikci Ertunc, Bernard P Kok, William H Parsons, et al.
Journal of Medicinal Chemistry|April 9, 2015
Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep)William H Parsons, Raul R Calvo, Wing Cheung, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2009
Discovery of a novel class of isoxazoline voltage gated sodium channel blockersPengcheng P Shao, Feng Ye, Ann E Weber, et al.
Alcoholism, Clinical and Experimental Research|April 1, 2006
Basis of the gabamimetic profile of ethanolG R Breese, H E Criswell, M Carta, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2009
Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic painPengcheng P Shao, Feng Ye, Ann E Weber, et al.
Journal of Medicinal Chemistry|December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel J Parks, William H Parsons, Raymond W Colburn, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
3-Amino-1,5-benzodiazepinones: potent, state-dependent sodium channel blockers with anti-epileptic activityScott B Hoyt, Clare London, Matthew J Wyvratt, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2005
Discovery of potent and use-dependent sodium channel blockers for treatment of chronic painJun Liang, Richard M Brochu, Charles J Cohen, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Benzamide derivatives as blockers of Kv1.3 ion channelShouwu Miao, Jianming Bao, Maria L Garcia, et al.
Pageof 43

Showing results (391-400 of 424) with videos related to

Sort By:
Pageof 43
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Potent immunosuppressive C32-O-arylethyl ether derivatives of ascomycin with reduced toxicityH M Armstrong, F Wong, M A Holmes, et al.
The Journal of Biological Chemistry|March 11, 2020
AIG1 and ADTRP are endogenous hydrolases of fatty acid esters of hydroxy fatty acids (FAHFAs) in miceMeric Erikci Ertunc, Bernard P Kok, William H Parsons, et al.
Journal of Medicinal Chemistry|April 9, 2015
Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep)William H Parsons, Raul R Calvo, Wing Cheung, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2009
Discovery of a novel class of isoxazoline voltage gated sodium channel blockersPengcheng P Shao, Feng Ye, Ann E Weber, et al.
Alcoholism, Clinical and Experimental Research|April 1, 2006
Basis of the gabamimetic profile of ethanolG R Breese, H E Criswell, M Carta, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2009
Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic painPengcheng P Shao, Feng Ye, Ann E Weber, et al.
Journal of Medicinal Chemistry|December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel J Parks, William H Parsons, Raymond W Colburn, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
3-Amino-1,5-benzodiazepinones: potent, state-dependent sodium channel blockers with anti-epileptic activityScott B Hoyt, Clare London, Matthew J Wyvratt, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2005
Discovery of potent and use-dependent sodium channel blockers for treatment of chronic painJun Liang, Richard M Brochu, Charles J Cohen, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Benzamide derivatives as blockers of Kv1.3 ion channelShouwu Miao, Jianming Bao, Maria L Garcia, et al.
Pageof 43